Overview
Coxopodopatellar syndrome, also known as small patella syndrome or Scott-Taor syndrome, is a rare genetic skeletal disorder primarily affecting the bones and joints of the lower extremities and pelvis. The hallmark features include hypoplasia (underdevelopment) or aplasia (absence) of the patella (kneecap), abnormalities of the pelvis such as hypoplasia of the ischiopubic junction, and foot anomalies including wide gaps between the first and second toes and flat feet. The condition is classified under skeletal dysplasias with predominant involvement of the limbs. Affected individuals may experience difficulties with knee stability and mobility due to the absent or small patella, which can lead to recurrent patellar dislocations and knee pain. Pelvic abnormalities, particularly ischiopubic hypoplasia, are a distinctive radiographic finding. Additional skeletal features may include short stature and other minor limb anomalies. The condition is caused by mutations in the TBX4 gene, which encodes a transcription factor critical for limb and pelvic development. There is no cure for coxopodopatellar syndrome, and management is primarily supportive and symptomatic. Treatment may include physical therapy to strengthen the muscles around the knee, orthopedic interventions such as bracing for knee instability, and in some cases surgical procedures to address patellar instability or foot deformities. Regular orthopedic follow-up is recommended to monitor skeletal development, particularly during childhood and adolescence. Genetic counseling is advised for affected families given the hereditary nature of the condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
FDA & Trial Timeline
5 eventsMedipol University — NA
Yandy Marx Castillo Aleman — EARLY_PHASE1
Kyverna Therapeutics
University of South Florida — PHASE2
SPS srl — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Coxopodopatellar syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Coxopodopatellar syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Coxopodopatellar syndrome.
Community
No community posts yet. Be the first to share your experience with Coxopodopatellar syndrome.
Start the conversation →Latest news about Coxopodopatellar syndrome
Disease timeline:
New recruiting trial: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A new clinical trial is recruiting patients for Coxopodopatellar syndrome
New recruiting trial: SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery
A new clinical trial is recruiting patients for Coxopodopatellar syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Coxopodopatellar syndrome
What is Coxopodopatellar syndrome?
Coxopodopatellar syndrome, also known as small patella syndrome or Scott-Taor syndrome, is a rare genetic skeletal disorder primarily affecting the bones and joints of the lower extremities and pelvis. The hallmark features include hypoplasia (underdevelopment) or aplasia (absence) of the patella (kneecap), abnormalities of the pelvis such as hypoplasia of the ischiopubic junction, and foot anomalies including wide gaps between the first and second toes and flat feet. The condition is classified under skeletal dysplasias with predominant involvement of the limbs. Affected individuals may expe
How is Coxopodopatellar syndrome inherited?
Coxopodopatellar syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Coxopodopatellar syndrome typically begin?
Typical onset of Coxopodopatellar syndrome is childhood. Age of onset can vary across affected individuals.
Which specialists treat Coxopodopatellar syndrome?
1 specialists and care centers treating Coxopodopatellar syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.